CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 85 enrolled
Drug / intervention
Simvastatin +2 moredrug
Likely dose
Simvastatin 40mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00587678
NCT00587678N/ACompleted
CompareCT.gov

Comprehensive Magnetic Resonance of Peripheral Arterial Disease

University of Virginia·interventional·Posted Jan 7, 2008·Updated Aug 21, 2017

In Brief

A clinical study evaluating Simvastatin, Ezetimibe, and 1 other intervention for Peripheral Artery Disease. Completed, enrolled 85 participants across 1 site.

Detailed Summary

The purpose of this study is to develop new ways of imaging fatty blockages in the leg arteries to improve upon techniques used now and to develop new ways of understanding how new treatments may affect the disease.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Artery Disease
CountriesUnited States
CollaboratorsNational Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)

Timeline

N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 7, 2008
Enrollment StartJan 1, 2006
Primary CompletionOct 1, 2009
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 18.5 years ago

Interventions

Simvastatindrug

40mg each night

Ezetimibedrug

10mg daily

Simvastatin/Ezetimibedrug

40mg/10mg each night